Percutaneous tricuspid valve repair: A safer alternative to traditional approaches?

Abstract

Tricuspid regurgitation (TR) is a common type of age-related valve disease associated with a poor prognosis, even in patients who receive optimal medical therapy. In patients who undergo isolated tricuspid valve (TV) surgery, the operative mortality rate is 10%. 1 Thus, additional approaches for managing TR are needed. The 2021 European Society of Cardiology/European Association for Cardio-Thoracic Surgery Guidelines for managing valvular heart disease suggested a potential role for the use of transcatheter TV intervention in patients with TR who are at high surgical risk. 2